
Sign up to save your podcasts
Or


Stay updated on recently FDA-approved medications crucial for pharmacists.
Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.
The GameChanger
SweatControl Patch approved for primary axillary hyperhidrosis.
Update in treatment for Alzheimer's with mild cognitive impairment.
Host
Joe Strain, PharmD
Clinical Faculty, Monument Health
South Dakota State College of Pharmacy
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the therapeutic indications of recent FDA-approved medications.
2. Describe unique pharmacological properties for each new medication.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-098-H01-P
Initial release date: 03/11/2024
Expiration date: 03/11/2025
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram
By CEimpact4.8
1717 ratings
Stay updated on recently FDA-approved medications crucial for pharmacists.
Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.
The GameChanger
SweatControl Patch approved for primary axillary hyperhidrosis.
Update in treatment for Alzheimer's with mild cognitive impairment.
Host
Joe Strain, PharmD
Clinical Faculty, Monument Health
South Dakota State College of Pharmacy
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the therapeutic indications of recent FDA-approved medications.
2. Describe unique pharmacological properties for each new medication.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-098-H01-P
Initial release date: 03/11/2024
Expiration date: 03/11/2025
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram

37,595 Listeners

38,950 Listeners

261 Listeners

4,794 Listeners

87,868 Listeners

3,374 Listeners

113,121 Listeners

35 Listeners

56,944 Listeners

171 Listeners

13,326 Listeners

3,754 Listeners

35 Listeners

28 Listeners

3 Listeners